NEW YORK, May 27, 2014 /PRNewswire/ — Case Funding Inc. has become the only litigation funding company uniquely positioned to offer a full suite of legal financing products to Attorneys and Law Firms who work on a contingency fee basis over the course of just three years. While the company itself has been active for over a decade, recapitalization and reorganization as a subsidiary of a publicly traded company have allowed Case Funding to include both Medical Funding and a well rounded Attorney Loan and Line of Credit program, which has become instrumental in assisting plaintiffs’ attorneys across the US.
“Unlike a bank, we are able to fully consider the true value of your portfolio of cases and create a funding package that’s appropriate for your short and long term needs. Equally important are our repayment terms, which allow you to repay the loan as you settle cases and receive your fees. Our goal is to provide you with the financial resources you need to maximize your cases for you and your clients grow your firm and prosper,” states VP of Attorney Relations, Leon Branam.
In honor of the anniversary, Case Funding will be celebrating at an event in Manhattan and offering promotions to trial attorneys at the upcoming APITLA seminar in St. Louis, MO. Interested parties can contact Leon Branam for more information.
ABOUT CASE FUNDING: Based in New York, Case Funding Inc. is one of the largest legal finance companies and an industry leader that provides working capital loans to attorneys, medical funding to uninsured plaintiffs, and presettlement advances to personal injury victims. Call 888-796-7594 to speak with one of our legal finance specialists and apply.
The “right to be forgotten” in the online sphere has recently been protected by the European Court of Justice (ECJ), the highest court in the European Union. According to this court’s recent ruling, Google and other search engines are responsible … Continue reading
“Case Funding is an excellent resource for your financial needs in any case, not only trucking cases. They are “The Real Deal” and you will find them to be great to work with.” -Dan Ramsdell, APITLA National Director Case Funding … Continue reading
Claimants’ Negotiating Counsel achieved a $650M Settlement in In Re Pradaxa (Dabigatran Etexilate) Products Liability Litigation, MDL No. 2385, hoping to resolve about 4,000 lawsuits against the drugmaker, Boehringer Ingelheim Pharmaceuticals, Inc. (BI). Plaintiffs’ steering committee was led by Roger … Continue reading